Cargando…

Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis

This study aimed at providing an updated evidence of the association between intraoperative lidocaine and risk of postcardiac surgery cognitive deficit. METHODS: Randomized clinical trials (RCTs) investigating effects of intravenous lidocaine against cognitive deficit in adults undergoing cardiac su...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Kuo-Chuan, Ho, Chun-Ning, Liu, Wei-Cheng, Yew, Ming, Chang, Ying-Jen, Lin, Yao-Tsung, Hung, I-Yin, Chen, Jen-Yin, Huang, Ping-Wen, Sun, Cheuk-Kwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439840/
https://www.ncbi.nlm.nih.gov/pubmed/36107567
http://dx.doi.org/10.1097/MD.0000000000030476
_version_ 1784782167402872832
author Hung, Kuo-Chuan
Ho, Chun-Ning
Liu, Wei-Cheng
Yew, Ming
Chang, Ying-Jen
Lin, Yao-Tsung
Hung, I-Yin
Chen, Jen-Yin
Huang, Ping-Wen
Sun, Cheuk-Kwan
author_facet Hung, Kuo-Chuan
Ho, Chun-Ning
Liu, Wei-Cheng
Yew, Ming
Chang, Ying-Jen
Lin, Yao-Tsung
Hung, I-Yin
Chen, Jen-Yin
Huang, Ping-Wen
Sun, Cheuk-Kwan
author_sort Hung, Kuo-Chuan
collection PubMed
description This study aimed at providing an updated evidence of the association between intraoperative lidocaine and risk of postcardiac surgery cognitive deficit. METHODS: Randomized clinical trials (RCTs) investigating effects of intravenous lidocaine against cognitive deficit in adults undergoing cardiac surgeries were retrieved from the EMBASE, MEDLINE, Google scholar, and Cochrane controlled trials register databases from inception till May 2021. Risk of cognitive deficit was the primary endpoint, while secondary endpoints were length of stay (LOS) in intensive care unit/hospital. Impact of individual studies and cumulative evidence reliability were evaluated with sensitivity analyses and trial sequential analysis, respectively. RESULTS: Six RCTs involving 963 patients published from 1999 to 2019 were included. In early postoperative period (i.e., 2 weeks), the use of intravenous lidocaine (overall incidence = 14.8%) was associated with a lower risk of cognitive deficit compared to that with placebo (overall incidence = 33.1%) (relative risk = 0.49, 95% confidence interval: 0.32–0.75). However, sensitivity analysis and trial sequential analysis signified insufficient evidence to arrive at a firm conclusion. In the late postoperative period (i.e., 6–10 weeks), perioperative intravenous lidocaine (overall incidence = 37.9%) did not reduce the risk of cognitive deficit (relative risk = 0.99, 95% confidence interval: 0.84) compared to the placebo (overall incidence = 38.6%). Intravenous lidocaine was associated with a shortened LOS in intensive care unit/hospital with weak evidence. CONCLUSION: Our results indicated a prophylactic effect of intravenous lidocaine against cognitive deficit only at the early postoperative period despite insufficient evidence. Further large-scale studies are warranted to assess its use for the prevention of cognitive deficit and enhancement of recovery (e.g., LOS).
format Online
Article
Text
id pubmed-9439840
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94398402022-09-06 Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis Hung, Kuo-Chuan Ho, Chun-Ning Liu, Wei-Cheng Yew, Ming Chang, Ying-Jen Lin, Yao-Tsung Hung, I-Yin Chen, Jen-Yin Huang, Ping-Wen Sun, Cheuk-Kwan Medicine (Baltimore) Research Article This study aimed at providing an updated evidence of the association between intraoperative lidocaine and risk of postcardiac surgery cognitive deficit. METHODS: Randomized clinical trials (RCTs) investigating effects of intravenous lidocaine against cognitive deficit in adults undergoing cardiac surgeries were retrieved from the EMBASE, MEDLINE, Google scholar, and Cochrane controlled trials register databases from inception till May 2021. Risk of cognitive deficit was the primary endpoint, while secondary endpoints were length of stay (LOS) in intensive care unit/hospital. Impact of individual studies and cumulative evidence reliability were evaluated with sensitivity analyses and trial sequential analysis, respectively. RESULTS: Six RCTs involving 963 patients published from 1999 to 2019 were included. In early postoperative period (i.e., 2 weeks), the use of intravenous lidocaine (overall incidence = 14.8%) was associated with a lower risk of cognitive deficit compared to that with placebo (overall incidence = 33.1%) (relative risk = 0.49, 95% confidence interval: 0.32–0.75). However, sensitivity analysis and trial sequential analysis signified insufficient evidence to arrive at a firm conclusion. In the late postoperative period (i.e., 6–10 weeks), perioperative intravenous lidocaine (overall incidence = 37.9%) did not reduce the risk of cognitive deficit (relative risk = 0.99, 95% confidence interval: 0.84) compared to the placebo (overall incidence = 38.6%). Intravenous lidocaine was associated with a shortened LOS in intensive care unit/hospital with weak evidence. CONCLUSION: Our results indicated a prophylactic effect of intravenous lidocaine against cognitive deficit only at the early postoperative period despite insufficient evidence. Further large-scale studies are warranted to assess its use for the prevention of cognitive deficit and enhancement of recovery (e.g., LOS). Lippincott Williams & Wilkins 2022-09-02 /pmc/articles/PMC9439840/ /pubmed/36107567 http://dx.doi.org/10.1097/MD.0000000000030476 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Hung, Kuo-Chuan
Ho, Chun-Ning
Liu, Wei-Cheng
Yew, Ming
Chang, Ying-Jen
Lin, Yao-Tsung
Hung, I-Yin
Chen, Jen-Yin
Huang, Ping-Wen
Sun, Cheuk-Kwan
Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis
title Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis
title_full Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis
title_fullStr Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis
title_full_unstemmed Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis
title_short Prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: A PRISMA-compliant meta-analysis and trial sequential analysis
title_sort prophylactic effect of intravenous lidocaine against cognitive deficit after cardiac surgery: a prisma-compliant meta-analysis and trial sequential analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439840/
https://www.ncbi.nlm.nih.gov/pubmed/36107567
http://dx.doi.org/10.1097/MD.0000000000030476
work_keys_str_mv AT hungkuochuan prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT hochunning prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT liuweicheng prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT yewming prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT changyingjen prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT linyaotsung prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT hungiyin prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT chenjenyin prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT huangpingwen prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis
AT suncheukkwan prophylacticeffectofintravenouslidocaineagainstcognitivedeficitaftercardiacsurgeryaprismacompliantmetaanalysisandtrialsequentialanalysis